Condition: Rheumatic Heart Disease · Anticoagulant Adverse Reaction · Sponsor: Helse Nord-Trøndelag HF
In this bi-directional program of education, training and research activities based on sustainable development goals aim is to develop cardiac surgery service in Ethiopia. The aim is to evaluate the short and long-term outcome of cardiac surgery for rheumatic heart disease in a low-income country compared to individuals not offered cardiac surgery due to limited availability of the service. Second aim is to evaluate the quality of anticoagulant therapy in patients after cardiac surgery for rheumatic heart disease in a low-income country .
This description comes directly from the study's public registry record.
Haavard Dalen, MD, PhD · 74098206 · havard.dalen@ntnu.no
Rune Haaverstad, MD, PhD · 55 97 22 20 · rune.haaverstad@helse-bergen.no
Always discuss trial participation with your own doctor first.
| Black Lion University Hospital | Addis Ababa, Ethiopia | Recruiting |
| Haukeland University Hospital | Bergen, Norway | Recruiting |
| Oslo University Hospital | Oslo, Norway | Recruiting |
| St. Olav University Hospital | Trondheim, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04556188